GMAP-210_TRIP11 Activators
GMAP-210_TRIP11 activators are chemical compounds that enhance the protein's functionality by modulating various intracellular pathways and components critical to its role in Golgi apparatus organization and vesicle trafficking. Forskolin and IBMX, for instance, both elevate cAMP levels; Forskolin does this directly, while IBMX prevents cAMP breakdown, thereby indirectly enhancing PKA activity. This enhancement of PKA can lead to phosphorylation events that bolster GMAP-210_TRIP11's tethering of the Golgi to microtubules. Similarly, Epigallocatechin gallate, by inhibiting competitive kinases, may shift the equilibrium towards pathways that support GMAP-210_TRIP11's stability and interactions within the cell. Phorbol 12-myristate 13-acetate (PMA) activates PKC, which could modulate the cytoskeleton and thus positively impact GMAP-210_TRIP11's interactions with the Golgi and microtubules. The functional activity of GMAP-210_TRIP11 is further supported by A23187, which increases intracellular calcium and activates signaling pathways that could promote its role in membrane dynamics. Sphingosine-1-phosphate, through receptor-mediated actin cytoskeleton rearrangement, and Paclitaxel, by stabilizing microtubules, each enhance GMAP-210_TRIP11's functional activity in Golgi positioning and vesicle tethering.
In addition to these, Okadaic Acid, through inhibition of protein phosphatases, creates a hyperphosphorylated state that may favor GMAP-210_TRIP11's interaction with other proteins, thereby enhancing its trafficking role. Nicotinamide impacts cellular metabolism and energy status, indirectly influencing GMAP-210_TRIP11's activity in Golgi dynamics. Lithium Chloride's inhibition of GSK-3 leads to microtubule stabilization, supporting GMAP-210_TRIP11's role in the Golgi structure maintenance. MG132 prevents proteasomal degradation of proteins, potentially increasing the levels of GMAP-210_TRIP11 regulators and cooperators, while Y-27632's inhibition of ROCK relaxes the actin cytoskeleton, thereby potentially facilitating GMAP-210_TRIP11's role in Golgi organization and vesicular transport.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly increases intracellular cAMP levels which can lead to the activation of PKA. PKA is known to phosphorylate a wide range of substrates including proteins that interact with GMAP-210_TRIP11, potentially altering its binding to the Golgi apparatus and enhancing its function in intracellular trafficking. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX acts as a nonspecific inhibitor of phosphodiesterases, which increases intracellular cAMP by preventing its breakdown. Elevated cAMP levels can enhance PKA activity, which in turn may positively influence GMAP-210_TRIP11's function in maintaining Golgi architecture and microtubule tethering. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This polyphenol inhibits a range of kinases, which could reduce competitive signaling pathways, indirectly enhancing the pathways that regulate GMAP-210_TRIP11 function in the organization of the Golgi apparatus and microtubule nucleation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC) which is involved in a variety of cellular functions. PKC activation can modulate the cytoskeleton and, as a result, may enhance GMAP-210_TRIP11's role in Golgi-microtubule interactions and vesicular trafficking. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels. This elevation in calcium can activate calcium-dependent signaling pathways, potentially impacting GMAP-210_TRIP11 activity through altered regulation of Golgi dynamics and membrane trafficking. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule activates sphingosine-1-phosphate receptors which can lead to actin cytoskeleton rearrangements. These rearrangements can influence the trafficking functions of GMAP-210_TRIP11 through changes in the dynamics of the Golgi and associated vesicular structures. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and may enhance GMAP-210_TRIP11's functional activity by promoting microtubule assembly and stability, which is critical for GMAP-210_TRIP11's role in Golgi apparatus positioning and vesicle tethering. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
As an inhibitor of protein phosphatases PP1 and PP2A, okadaic acid can lead to increased phosphorylation of a variety of proteins. This hyperphosphorylated environment could affect GMAP-210_TRIP11 function by influencing its interactions with other proteins and its stability, possibly enhancing its role in membrane trafficking. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide, a form of vitamin B3, acts as a precursor for NAD+ which is a substrate for sirtuins, a class of deacetylase enzymes. Its role in cellular metabolism could indirectly affect the function of GMAP-210_TRIP11 by modulating the energy status of the cell and thus influencing Golgi dynamics and membrane trafficking. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase 3 (GSK-3), which might lead to the stabilization of microtubules. This stabilization can enhance GMAP-210_TRIP11 activity in the maintenance of Golgi structure and trafficking processes due to the close interplay between microtubules and the Golgi complex. | ||||||